In Other News

• Plug-and-Play AI Pathology System Classifies Multiple Cancers from Few Slides

• Cancer-Related Mutations in Immune Cells Linked to Alzheimer’s

• Oral–Gut Microbiome Signatures Identify Early Gastric Cancer

• AI-Based Assays Support Risk Stratification in Prostate and Breast Cancer

• Microneedle Sensor Enables Continuous Monitoring of Drug Clearance

• Label-Free Microscopy Methodd Enables Faster, Quantitative Detection of Malaria

• Composite Blood Biomarkers Enable Early Detection of Common Cancers

• Single Assay Enables Rapid HLA and ABO Genotyping for Transplant Matching

• Cancer-Related Mutations in Immune Cells Linked to Alzheimer’s

• Gut Microbiome Test Predicts Melanoma Recurrence After Surgery

• AI Pathology Model Predicts Immunotherapy Response in Lung Cancer

• Prognostic Biomarker Identified in Diffuse Large B-Cell Lymphoma

• Gut Microbiome Test Predicts Melanoma Recurrence After Surgery

• Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

• Blood Test Enables Early Detection and Classification of Glioma

• Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

• Rapid Blood-Culture Susceptibility Panel Expands Coverage for Gram-Negative Infections

• QuidelOrtho Adds Ultra-Fast PCR Platform with LEX Acquisition

• Antibiotic Resistance Genes Found in Newborns Within Hours of Birth

• Multi-Biomarker Blood Test Detects Early-Stage Cancers Across Types

• New Sample-to-Answer PCR System Supports High-Throughput Infectious Disease Testing

• Seegene Showcases Real-Time PCR Data Analytics Platform at ESCMID

• Seegene Showcases Real-Time PCR Data Analytics Platform at ESCMID